NCT02096055View on ClinicalTrials.gov

Guadecitabine With or Without Idarubicin or Cladribine in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia

PHASE2CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

April 4, 2014

Primary Completion Date

November 24, 2020

Study Completion Date

November 24, 2020

Conditions
Untreated Adult Acute Myeloid Leukemia
Interventions
DRUG

Cladribine

Given IV

DRUG

Guadecitabine

Given SC

DRUG

Idarubicin

Given IV

Trial Locations (1)

77030

M D Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER

NCT02096055 - Guadecitabine With or Without Idarubicin or Cladribine in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia | Biotech Hunter | Biotech Hunter